Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - febuxostat hemihydrate 82 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - febuxostat hemihydrate 123,4 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.4 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - febuxostat hemihydrate 82,28 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82.28 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - febuxostat hemihydrate 123,42 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.42 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 123,42 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.42 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 82,28 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82.28 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 123,42 mg - eq. febuxostat 120 mg - film-coated tablet - 120 mg - febuxostat hemihydrate 123.42 mg - febuxostat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - febuxostat hemihydrate 82,28 mg - eq. febuxostat 80 mg - film-coated tablet - 80 mg - febuxostat hemihydrate 82.28 mg - febuxostat

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout preparations - febuxostat mylan is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (tls).febuxostat mylan is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).febuxostat mylan is indicated in adults.

European Union - English - EMA (European Medicines Agency)

krka, d.d., novo mesto - febuxostat - hyperuricemia; gout - antigout preparations - febuxostat krka is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).febuxostat krka is indicated in adults.